メドミラは,FY 2024年度の収入の15%上昇を報告し,医療のさらなる拡大を計画している. MedMira reports a 15% revenue rise for FY 2024 and plans further expansion in healthcare.

医療技術企業であるメドミラは,2024年度第4四半期と全年の財務結果を公表しました. MedMira, a healthcare technology company, has released its financial results for the fourth quarter and full year of fiscal year 2024. 同社は,前年度の15%の収入増加を報告し,所得は利息,税,減価償却,償還率(EBITDA)の10%を上回る. The company reported a revenue increase of 15% over the previous year, with earnings before interest, taxes, depreciation, and amortization (EBITDA) up by 10%. メドミラはまた,医療市場への進出を促進するため,来年の事業拡大の計画を発表した. MedMira also announced plans for expanding its operations in the coming year to further penetrate the healthcare market.

記事

LeLézard

PharmiWeb

Finanz Nachrichten

-- 表示を減らす --

関連記事